Literature DB >> 12946570

Epitope mapping and specificity of the anti-alpha-synuclein monoclonal antibody Syn-1 in mouse brain and cultured cell lines.

R J Perrin1, J E Payton, D H Barnett, C L Wraight, W S Woods, L Ye, J M George.   

Abstract

While alpha- and beta-synuclein largely overlap in their expression in the vertebrate brain, only alpha-synuclein accumulates in the fibrillar aggregates typical of Parkinson's disease. It is thus critical to have immunological reagents that distinguish between these two protein isoforms. The monoclonal antibody Syn-1 (Transduction Labs) has been frequently used for the specific detection of alpha-synuclein. In this report, the epitope for Syn-1 is localized within residues 91-99 of human alpha-synuclein. Sequence differences exist in this domain that account for the specificity of Syn-1 for alpha- versus beta-synuclein. However, Syn-1 also displays reactivity with additional species (approximately 45 kDa) in brain homogenates from both wild-type and alpha-synuclein null mice, indicating a potential for cross-reactivity with a protein species that is unrelated to alpha-synuclein in brain tissue or extracts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12946570     DOI: 10.1016/s0304-3940(03)00781-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  27 in total

1.  Synuclein expression in the lizard Anolis carolinensis.

Authors:  Mattia Toni; Carla Cioni; Federica De Angelis; Maria Carmela Bonaccorsi di Patti
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2016-07-08       Impact factor: 1.836

2.  α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer.

Authors:  Bruno Fauvet; Martial K Mbefo; Mohamed-Bilal Fares; Carole Desobry; Sarah Michael; Mustafa T Ardah; Elpida Tsika; Philippe Coune; Michel Prudent; Niels Lion; David Eliezer; Darren J Moore; Bernard Schneider; Patrick Aebischer; Omar M El-Agnaf; Eliezer Masliah; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

3.  Sensitivity and specificity of phospho-Ser129 α-synuclein monoclonal antibodies.

Authors:  Vedad Delic; Sidhanth Chandra; Hisham Abdelmotilib; Tyler Maltbie; Shijie Wang; Danielle Kem; Hunter J Scott; Rachel N Underwood; Zhiyong Liu; Laura A Volpicelli-Daley; Andrew B West
Journal:  J Comp Neurol       Date:  2018-08-15       Impact factor: 3.215

4.  Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat.

Authors:  Robert J Phillips; Gary C Walter; Brittany E Ringer; Katherine M Higgs; Terry L Powley
Journal:  Exp Neurol       Date:  2009-08-05       Impact factor: 5.330

5.  Cysteine cathepsins are essential in lysosomal degradation of α-synuclein.

Authors:  Ryan P McGlinchey; Jennifer C Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

6.  Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein.

Authors:  Dominique Bétemps; Jérémy Verchère; Anne-Laure Mougenot; Ingolf Lachmann; Eric Morignat; Emilie Antier; Latifa Lakhdar; Stéphane Legastelois; Thierry Baron
Journal:  J Vis Exp       Date:  2015-05-30       Impact factor: 1.355

7.  In vivo cross-linking reveals principally oligomeric forms of α-synuclein and β-synuclein in neurons and non-neural cells.

Authors:  Ulf Dettmer; Andrew J Newman; Eric S Luth; Tim Bartels; Dennis Selkoe
Journal:  J Biol Chem       Date:  2013-01-14       Impact factor: 5.157

8.  Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD.

Authors:  Silke Nuber; Daniel Tadros; Jerel Fields; Cassia Rose Overk; Benjamin Ettle; Kori Kosberg; Michael Mante; Edward Rockenstein; Margarita Trejo; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2014-02-08       Impact factor: 17.088

9.  Axonopathy in an α-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of C-terminal-truncated α-synuclein.

Authors:  Dora Games; Peter Seubert; Edward Rockenstein; Christina Patrick; Margarita Trejo; Kiren Ubhi; Benjamin Ettle; Majid Ghassemiam; Robin Barbour; Dale Schenk; Silke Nuber; Eliezer Masliah
Journal:  Am J Pathol       Date:  2013-01-09       Impact factor: 4.307

10.  Interference of α-Synuclein Uptake by Monomeric β-Amyloid1-40 and Potential Core Acting Site of the Interference.

Authors:  Daniel K Y Chan; Nady Braidy; Ying Hua Xu; Tim Chataway; Feng Guo; Gilles J Guillemin; Charlie Teo; Wei Ping Gai
Journal:  Neurotox Res       Date:  2016-06-30       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.